Personalized Kampo Medicine Facilitated Both Cytotoxic T Lymphocyte Response and Clinical Benefits Induced by Personalized Peptide Vaccination for Advanced Esophageal Cancer

We retrospectively evaluated if personalized Kampo medicine (PKM) could facilitate CTL responses and clinical benefits induced by personalized peptide vaccination (PPV), in which HLA-matched vaccines were selected and administered based on the preexisting host immunity, for advanced esophageal cance...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Evid Based Complement Alternat Med
Auteurs principaux: Muroya, Daisuke, Yutani, Shigeru, Shichijo, Shigeki, Yamada, Akira, Sakamoto, Shinjiro, Naito, Masayasu, Okuda, Koji, Morita, Michi, Yamaguchi, Rin, Itoh, Kyogo
Format: Artigo
Langue:Inglês
Publié: Hindawi Publishing Corporation 2016
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5040795/
https://ncbi.nlm.nih.gov/pubmed/27703488
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/5929525
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires